TriStart DHA (CarWin Pharmaceutical Associates, LLC)
Welcome to the PulseAid listing for the TriStart DHA drug offered from CarWin Pharmaceutical Associates, LLC. This Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | CarWin Pharmaceutical Associates, LLC |
NON-PROPRIETARY NAME: | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARB |
SUBSTANCE NAME: | ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, D-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; LEVOMEFOLATE MAGNESIUM; FOLIC ACID; CYANOCOBALAMIN; IRON PENTACARB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, LIQUID FILLED |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2015-06-01 |
END MARKETING DATE: | 0000-00-00 |
TriStart DHA HUMAN PRESCRIPTION DRUG Details:
Item Description | TriStart DHA from CarWin Pharmaceutical Associates, LLC |
LABELER NAME: | CarWin Pharmaceutical Associates, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 55; 1000; 15; 1.3; 1.8; 5; 35; 600; 400; 14; 31; 200; 30; 200; 15(mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2015-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 15370-250_80999e4b-a99b-4abd-b082-0ac6febebb1d |
PRODUCT NDC: | 15370-250 |
APPLICATION NUMBER: | |
Other ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, D-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; LEVOMEFOLATE MAGNESIUM; FOLIC ACID; CYANOCOBALAMIN; IRON PENTACARB Pharmaceutical Manufacturers / Labelers: